WallStreetZenWallStreetZen

NASDAQ: ALZN
Alzamend Neuro Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Alzamend Neuro earnings were -$9.1M for the trailing 12 months ending Jul 31, 2026, with N/A growth year over year. The latest ALZN earnings report on Jul 31, 2026 announced Q3 2026 earnings of -$3.0M, up 5.5% from last quarter. For the last reported fiscal year 2026 ending Apr 30, 2026, ALZN reported annual earnings of -$8.8M, with 71.8% growth.

ALZN earnings history

Current Revenue
$0.0
Current Earnings
-$9.1M
Current Profit Margin
0%

ALZN Return on Equity

Current Company
-277.9%
Current Industry
-10.8%
Current Market
30.9%
ALZN's Return on Equity (-277.9%)... subscribe to Premium to read more.
High Return on Equity Performance

ALZN Return on Assets

Current Company
-184.2%
Current Industry
-10.7%
ALZN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ALZN announces earnings.

ALZN Return on Capital Employed

Current Company
-156.66%
Current Industry
-7.4%
ALZN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALZN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ALZN-$8.98M-$9.10MN/A-$2.30
ENVB-$8.57M-$12.09MN/A-$13.15
BOLT-$25.19M-$28.74MN/A-$16.51
ACXP-$7.51M-$7.51MN/A-$2.69
ENLV$4.16B$3.19BN/A$529.40
View Top Biotech Stocks

Alzamend Neuro Earnings Reports & History FAQ

What were Alzamend Neuro's earnings last quarter?

On ALZN's earnings call on Jul 28, 2026, Alzamend Neuro (NASDAQ: ALZN) reported Q2 2026 earnings per share (EPS) of -$0.68, up 46.88% year over year. Total ALZN earnings for the quarter were -$3.03 million. In the same quarter last year, Alzamend Neuro's earnings per share (EPS) was -$1.28.

If you're new to stock investing, here's how to buy Alzamend Neuro stock.

Is Alzamend Neuro profitable or losing money?

As of the last Alzamend Neuro earnings report, Alzamend Neuro is currently losing money. Alzamend Neuro's net profit (also called net income) for the twelve months ending Jul 31, 2026 was -$9.10 million, a 45.71% increase year over year.

What was ALZN's earnings growth in the past year?

As of Alzamend Neuro's earnings date in Jul 28, 2026, Alzamend Neuro's earnings has grown year over year. ALZN earnings in the past year totalled -$9.10 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.